Multiple Myeloma – Mayo Clinic In the following video, Rafael Fonseca, M.D., Director of the Cancer Center at Mayo Clinic in Arizona, provides an overview of the condition Multiple Myeloma (a cancer that arises from the blood marrow) and describes treatment options. To learn more about Multiple Myeloma, visit: https://mayocl.in/2N4dM48 To request an appointment at […]
Read More
Update on diagnosis and therapy of plasma cell dyscrasias Department of Medicine Grand Rounds presentation by Dr. Kenneth C. Anderson, MD, Kraft Family Professor of Medicine Director, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School
Read More
What is multiple myeloma? | Hematologic System Diseases | NCLEX-RN | Khan Academy Created by Matthew McPheeters. Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/hematologic-system-diseases/rn-plasma-cell-dyscrasias/v/what-is-waldenstrom-macroglobulinemia?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/hematologic-system-diseases/rn-plasma-cell-dyscrasias/v/what-is-monoclonal-gammopathy-of-undetermined-significance-mgus?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States License (available […]
Read More
Single radiotherapy dose effective for breast cancer The trial evaluated up to 19-year outcomes of women treated with targeted intraoperative radiotherapy (TARGIT), a form of radiotherapy delivered directly to the affected area during lumpectomy surgery. Targeted intraoperative radiotherapy is believed to result in lower costs and fewer visits for patients. The vast majority of TARGIT […]
Read More
Cancer Biomarkers Market – Current Industry Size and Future Prospective with Key Players … The report titled on “Cancer Biomarkers Market” provides in-depth analysis of Product Scope, Market Overview, Market Opportunities, Market Driving Force and Market Risks. Cancer Biomarkers Market competitive landscapes provides details by Vendors, Including Company Overview, Company Total Revenue (Financials), Market Potential, […]
Read More
Bayer: Prostate cancer drug approved in China Bayer AG said Thursday that its prostate cancer drug Xofigo, or radium-223 dichloride, was approved by the Chinese Medical Products Administration. The drug, which is defined as a Targeted Alpha Therapy, is indicated in the treatment of patients with castration-resistant prostate cancer who also have symptomatic bone metasthases […]
Read More
NCCN Meeting on Blood Cancers Will Be Virtual for the First Time The NCCN Virtual Nursing Forum and Annual Congress: Hematologic Malignancies (#NCCNhem2020) will provide the latest evidence and expert consensus on emerging practices and debates in blood cancer treatment, online October 8-10. PLYMOUTH MEETING, Pennsylvania, Aug. 27, 2020 /PRNewswire/ — The National Comprehensive Cancer Network® […]
Read More
Signs and Symptoms of blood cancer ‘Early diagnosis saves lives’. As with many other cancers, the earlier blood cancer is picked up and diagnosed, the better the treatment outcomes are. Because of the vagueness of the symptoms, which include tiredness, frequent infections, itchy skin, night sweats, sore bones and bruising, 33% – 10,000 cases – […]
Read More
3D Cell Culture Systems in Cancer Organoids Reveal Drug Efficacy that is Undetectable in … CARDIFF, UK, August 26, 2020 / B3C newswire / — A new paper exploring the application of patient-derived organoids (PDOs) in the study of novel inhibitors of stem cell activity has recently been published in the journal PLOS ONE (Badder […]
Read More
Radiation for young adult cancer linked to worse BC survival in premenopausal women Bottom Line: Among premenopausal women with breast cancer, those who were previously treated with radiation for a primary childhood, adolescent, or young adult cancer had worse breast cancer-specific survival. Journal in Which the Study was Published: Cancer Epidemiology, Biomarkers & Prevention, a […]
Read More